Skip to main content

Glaxo Buys Two More MassARRAYs From Sequenom

NEW YORK, Oct. 17 - Sequenom today said that GlaxoSmithKline likes its MassARRAY tools it bought earlier this year and has opened its wallet for two more units.

 

The sale also follows a collaboration between the two firms that helped Sequenom generate a "significant portion" of its SNP-assay portfolio, the company said.

 

Click here for more information.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.